SAILONG PHARMACEUTICAL GROUP CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.29 CNY | +0.98% |
|
-3.20% | -26.34% |
| 04-19 | Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-08 | Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Sailong Pharmaceutical Group Co Ltd, formerly Zhuhai Sailong Pharmaceutical Co Ltd, is a China-based company principally engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations, as well as providing technical services. The Companyâs main products include monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others. Through its subsidiaries, the Company is also engaged in the sales of scraps, provision of technical services and sales promotion. The Company mainly conducts its businesses with domestic market.
Sector
Pharmaceuticals
Calendar
03:00am
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -26.34% | 248M | |
| +21.98% | 43.92B | |
| +24.56% | 23.09B | |
| +19.25% | 15.35B | |
| +14.03% | 13.61B | |
| +46.40% | 12.02B | |
| -10.14% | 7B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.07% | 5.6B |
- Stock Market
- Equities
- 002898 Stock
- News Sailong Pharmaceutical Group Co.,Ltd.
- Sailong Pharma's Unit Gets Nod to Market Pregabalin